Transgene SA (FRA:TGNA)
Germany · Delayed Price · Currency is EUR 0.9040
-0.0160 (-1.74%)
Last updated: Jan 19, 2026, 8:19 AM CET
Transgene Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 0.04 | 0.04 | 1.18 | 3.13 | 9.99 | 2.98 |
Other Revenue | 7.54 | 6.32 | 6.72 | 7.22 | 7.25 | 6.59 |
| 7.58 | 6.35 | 7.9 | 10.34 | 17.24 | 9.57 | |
Revenue Growth (YoY) | 16.65% | -19.58% | -23.63% | -40.00% | 80.08% | -28.00% |
Cost of Revenue | 36.77 | 34.28 | 29.59 | 32.17 | 32.88 | 27.35 |
Gross Profit | -29.19 | -27.93 | -21.69 | -21.82 | -15.64 | -17.77 |
Selling, General & Admin | 6.99 | 7.76 | 6.99 | 7.91 | 7.37 | 6.55 |
Other Operating Expenses | 0.04 | -0.03 | 1.34 | 0.16 | 0.68 | 0.02 |
Operating Expenses | 7.03 | 7.73 | 8.32 | 8.07 | 8.05 | 6.56 |
Operating Income | -36.22 | -35.66 | -30.01 | -29.9 | -23.7 | -24.34 |
Interest Expense | -2.06 | -1.68 | -0.17 | -0.8 | -0.46 | -1.96 |
Interest & Investment Income | 2.5 | 2.59 | 8.08 | 2.48 | 0.8 | 0.09 |
Currency Exchange Gain (Loss) | -1.02 | 0.78 | -0.19 | 0.11 | 0.17 | -0.01 |
Other Non Operating Income (Expenses) | 0.02 | - | - | -19.03 | -0.13 | -0.1 |
EBT Excluding Unusual Items | -36.78 | -33.97 | -22.29 | -47.14 | -23.32 | -26.31 |
Gain (Loss) on Sale of Investments | - | - | - | 14.35 | 3.79 | 9.08 |
Gain (Loss) on Sale of Assets | -0 | -0 | -0.04 | -0.01 | -0 | - |
Pretax Income | -36.78 | -33.97 | -22.33 | -32.8 | -19.54 | -17.23 |
Earnings From Continuing Operations | -36.78 | -33.97 | -22.33 | -32.8 | -19.54 | -17.23 |
Net Income | -36.78 | -33.97 | -22.33 | -32.8 | -19.54 | -17.23 |
Net Income to Common | -36.78 | -33.97 | -22.33 | -32.8 | -19.54 | -17.23 |
Shares Outstanding (Basic) | 132 | 117 | 101 | 100 | 91 | 82 |
Shares Outstanding (Diluted) | 132 | 117 | 101 | 100 | 91 | 82 |
Shares Change (YoY) | 30.91% | 15.98% | 1.09% | 9.21% | 11.04% | 0.36% |
EPS (Basic) | -0.28 | -0.29 | -0.22 | -0.33 | -0.21 | -0.21 |
EPS (Diluted) | -0.28 | -0.29 | -0.22 | -0.33 | -0.21 | -0.21 |
Free Cash Flow | -24.3 | -26.61 | -37.34 | -21.8 | -26.58 | -29.55 |
Free Cash Flow Per Share | -0.18 | -0.23 | -0.37 | -0.22 | -0.29 | -0.36 |
Gross Margin | - | - | -274.53% | -210.98% | -90.75% | -185.66% |
Operating Margin | -478.15% | -561.23% | -379.90% | -289.04% | -137.45% | -254.21% |
Profit Margin | -485.56% | -534.72% | -282.63% | -317.13% | -113.32% | -180.00% |
Free Cash Flow Margin | -320.81% | -418.92% | -472.63% | -210.75% | -154.19% | -308.71% |
EBITDA | -34.9 | -34.37 | -28.44 | -28.21 | -21.24 | -22.64 |
EBITDA Margin | - | - | - | -272.74% | -123.22% | -236.48% |
D&A For EBITDA | 1.32 | 1.28 | 1.57 | 1.69 | 2.45 | 1.7 |
EBIT | -36.22 | -35.66 | -30.01 | -29.9 | -23.7 | -24.34 |
EBIT Margin | - | - | - | -289.04% | -137.45% | -254.20% |
Revenue as Reported | 7.58 | 6.35 | 7.9 | 10.34 | 17.41 | 9.92 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.